Litcius/Paper detail

20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight

Satyam Singh, Sushabhan Sadhukhan, Avinash Sonawane

2023Biochimica et Biophysica Acta (BBA) - Reviews on Cancer92 citationsDOI

Topics & Concepts

GefitinibMedicineEpidermal growth factor receptorLung cancerEGFR inhibitorsErlotinibTyrosine kinaseTargeted therapyCancerCancer researchDrug resistanceBioinformaticsOncologyInternal medicineBiologyReceptorMicrobiologyProtein Degradation and InhibitorsCancer therapeutics and mechanismsLung Cancer Treatments and Mutations
20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight | Litcius